Prolexus Bhd
KLSE:PRLEXUS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Prolexus Bhd
KLSE:PRLEXUS
|
MY |
|
C
|
Careium AB (publ)
STO:CARE
|
SE |
|
D
|
Defence Therapeutics Inc
CNSX:DTC
|
CA |
|
A
|
Amplifon SpA
LSE:0N61
|
IT |
Balance Sheet
Balance Sheet Decomposition
Prolexus Bhd
Prolexus Bhd
Balance Sheet
Prolexus Bhd
| Jul-2014 | Jul-2015 | Jul-2016 | Jul-2017 | Jul-2018 | Jul-2019 | Jul-2020 | Jul-2021 | Jul-2022 | Jul-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
32
|
27
|
49
|
63
|
35
|
51
|
90
|
43
|
51
|
58
|
|
| Cash |
32
|
27
|
49
|
63
|
35
|
51
|
90
|
43
|
51
|
58
|
|
| Short-Term Investments |
3
|
6
|
59
|
42
|
4
|
15
|
14
|
81
|
62
|
81
|
|
| Total Receivables |
27
|
59
|
77
|
71
|
81
|
77
|
63
|
39
|
79
|
60
|
|
| Accounts Receivables |
26
|
55
|
67
|
61
|
65
|
70
|
61
|
35
|
73
|
54
|
|
| Other Receivables |
1
|
3
|
9
|
9
|
16
|
7
|
3
|
4
|
6
|
6
|
|
| Inventory |
22
|
23
|
21
|
11
|
30
|
40
|
43
|
32
|
33
|
29
|
|
| Other Current Assets |
4
|
6
|
0
|
0
|
0
|
6
|
16
|
18
|
0
|
0
|
|
| Total Current Assets |
89
|
121
|
206
|
187
|
150
|
188
|
227
|
214
|
226
|
229
|
|
| PP&E Net |
58
|
68
|
83
|
107
|
188
|
203
|
201
|
180
|
187
|
181
|
|
| PP&E Gross |
58
|
68
|
0
|
0
|
0
|
203
|
201
|
180
|
0
|
0
|
|
| Accumulated Depreciation |
37
|
44
|
0
|
0
|
0
|
53
|
63
|
73
|
0
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
|
| Goodwill |
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
|
| Long-Term Investments |
0
|
0
|
1
|
1
|
1
|
2
|
2
|
1
|
1
|
1
|
|
| Other Long-Term Assets |
1
|
1
|
12
|
12
|
11
|
11
|
0
|
0
|
0
|
0
|
|
| Other Assets |
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
|
| Total Assets |
150
N/A
|
192
+28%
|
304
+58%
|
309
+2%
|
352
+14%
|
407
+15%
|
432
+6%
|
398
-8%
|
417
+5%
|
417
0%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
16
|
20
|
27
|
4
|
18
|
20
|
11
|
5
|
8
|
7
|
|
| Accrued Liabilities |
13
|
22
|
0
|
0
|
0
|
13
|
14
|
12
|
0
|
0
|
|
| Short-Term Debt |
6
|
6
|
0
|
0
|
0
|
18
|
15
|
13
|
28
|
25
|
|
| Current Portion of Long-Term Debt |
1
|
1
|
14
|
8
|
38
|
8
|
10
|
0
|
1
|
1
|
|
| Other Current Liabilities |
7
|
11
|
41
|
45
|
24
|
25
|
36
|
12
|
21
|
15
|
|
| Total Current Liabilities |
43
|
60
|
82
|
57
|
80
|
84
|
86
|
43
|
57
|
48
|
|
| Long-Term Debt |
4
|
3
|
8
|
6
|
23
|
67
|
70
|
62
|
51
|
38
|
|
| Deferred Income Tax |
2
|
2
|
2
|
2
|
2
|
1
|
0
|
1
|
1
|
0
|
|
| Minority Interest |
8
|
12
|
16
|
24
|
24
|
27
|
29
|
29
|
30
|
30
|
|
| Total Liabilities |
57
N/A
|
78
+36%
|
107
+38%
|
90
-16%
|
129
+44%
|
179
+39%
|
185
+3%
|
134
-27%
|
139
+4%
|
115
-18%
|
|
| Equity | |||||||||||
| Common Stock |
41
|
58
|
88
|
123
|
123
|
105
|
106
|
126
|
126
|
126
|
|
| Retained Earnings |
51
|
52
|
110
|
98
|
102
|
124
|
142
|
139
|
152
|
176
|
|
| Additional Paid In Capital |
1
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Treasury Stock |
2
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
|
| Other Equity |
1
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
93
N/A
|
114
+23%
|
196
+72%
|
220
+12%
|
223
+2%
|
228
+2%
|
247
+8%
|
264
+7%
|
278
+5%
|
302
+9%
|
|
| Total Liabilities & Equity |
150
N/A
|
192
+28%
|
304
+58%
|
309
+2%
|
352
+14%
|
407
+15%
|
432
+6%
|
398
-8%
|
417
+5%
|
417
0%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
127
|
132
|
256
|
261
|
261
|
261
|
263
|
267
|
272
|
275
|
|